Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor
Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor
Recruiting · NCT05103345 · Registry updated 2026-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-08-27 | NCT05103345 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Guangzhou Sinogen Pharmaceutical Co., Ltd | 2 |
| Pharmaron | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| China Medical University Hospital | Taichung | Taiwan | 54 |
| Guangdong Clifford Hospital | Guangzhou | China | 2 |
| Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare | New Taipei City | Taiwan | 2 |
| West China Hospital of Sichuan University | Chengdu | China | 117 |